Therefore, although the mere presence of TH17 or TH17.1 cells is not sufficient as a conclusive marker for sarcoidosis, changes in TH17 and TH17.1 cell levels, combined with increased amounts of TGF-β1, IFN-γ, or IL-17A, can provide valuable insights into disease severity and progression. This evidence concerns the gene IFNG and sarcoidosis.